Cheviot Value Management’s Connect Biopharma Holdings CNTB Stock Holding History

Cheviot Value Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.4K	Buy	+22,165	New	+$45.3K	﹤0.01%	264

Other funds holding CNTB

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Cheviot Value Management's CNTB Position: Q3 2026 in Review

Cheviot Value Management opened a new position in Connect Biopharma Holdings (CNTB) in Q3 2026: 22,165 shares worth $24.4K. The stake represents ﹤0.01% of the portfolio and ranks #264 among its holdings.

18 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

Cheviot Value Management held 22,165 shares of Connect Biopharma Holdings worth $24.4K as of Q3 2026.
Connect Biopharma Holdings was a new Cheviot Value Management position in Q3 2026.
Connect Biopharma Holdings made up ﹤0.01% of Cheviot Value Management's portfolio in Q3 2026, its #264 holding.
18 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on Cheviot Value Management's 13F filing for Q3 2026, filed 9 Nov 2026.